Study of BGB-11417 in Adult Participants With Mature B-cell Malignancies
Clinical trial NCT04883957 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04883957
- Sponsor
- BeiGene
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-05
- Primary completion
- 2026-08-31
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.